# Éva Szabó

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/eva-szabo/

## Facts

| Field | Value |
| --- | --- |
| Citations | 11,887 |
| Field | Glycosylation and Glycoproteins Research |
| h-index | 54 |
| i10-index | 137 |
| Last Known Institution | National Institutes of Health |
| OpenAlex ID | https://openalex.org/A5020366697 |
| ORCID iD | 0000-0003-3891-0942 |
| Works | 548 |

## Researcher papers

- [Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis](https://scholariq.org/papers/requirement-for-ceramide-initiated-sapk-jnk-signalling-in-stress-induced/)
- [Metformin and Cancer Risk and Mortality: A Systematic Review and Meta-analysis Taking into Account Biases and Confounders](https://scholariq.org/papers/metformin-and-cancer-risk-and-mortality-a-systematic-review-and-meta-analysis/)
- [Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors.](https://scholariq.org/papers/use-of-a-monoclonal-anti-estrogen-receptor-antibody-in-the-immunohistochemical/)
- [Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor gamma in non-small cell lung cancer.](https://scholariq.org/papers/induction-of-differentiation-and-apoptosis-by-ligands-of-peroxisome-proliferator/)
- [Cancer and Inflammation: Promise for Biologic Therapy](https://scholariq.org/papers/cancer-and-inflammation-promise-for-biologic-therapy/)
- [Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial](https://scholariq.org/papers/sunitinib-in-patients-with-chemotherapy-refractory-thymoma-and-thymic-carcinoma/)
- [Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer—A Plan to Move Forward](https://scholariq.org/papers/progress-in-chemoprevention-drug-development-the-promise-of-molecular-biomarkers/)
- [Airway PI3K Pathway Activation Is an Early and Reversible Event in Lung Cancer Development](https://scholariq.org/papers/airway-pi3k-pathway-activation-is-an-early-and-reversible-event-in-lung-cancer/)
- [Phase I and Pharmacologic Study of 17-(Allylamino)-17-Demethoxygeldanamycin in Adult Patients With Solid Tumors](https://scholariq.org/papers/phase-i-and-pharmacologic-study-of-17-allylamino-17-demethoxygeldanamycin-in/)
- [Molecular Profiling and Targeted Therapy for Advanced Thoracic Malignancies: A Biomarker-Derived, Multiarm, Multihistology Phase II Basket Trial](https://scholariq.org/papers/molecular-profiling-and-targeted-therapy-for-advanced-thoracic-malignancies-a/)
- [Local ablative therapy (LAT) for oligoprogressive, EGFR-mutant, non-small cell lung cancer (NSCLC) after treatment with osimertinib.](https://scholariq.org/papers/local-ablative-therapy-lat-for-oligoprogressive-egfr-mutant-non-small-cell-lung/)

## Researcher topics

- [Glycosylation and Glycoproteins Research](https://scholariq.org/topics/glycosylation-and-glycoproteins-research/)
- [Cancer Research and Treatments](https://scholariq.org/topics/cancer-research-and-treatments/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Myasthenia Gravis and Thymoma](https://scholariq.org/topics/myasthenia-gravis-and-thymoma/)

## Researcher university

- [National Institutes of Health](https://scholariq.org/institutions/national-institutes-of-health/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.